New Analysis Demonstrates the Efficacy of RINVOQ® (upadacitinib) in Atopic Dermatitis with ...
AbbVie (NYSE: ABBV) today announced positive results from a new post-hoc analysis from the Measure Up 1 and Measure Up 2 Phase 3 studies. The analysis evaluated the efficacy of upadacitinib (15 mg or ...
vipmagazine3 小时
How to prevent eczema flare-ups as the weather gets colder
September is Eczema Awareness Month - and if you've any experience with the condition you'll know just how debilitating it can be.
New Data Shows ZORYVE® (Roflumilast) Cream 0.15% Provided Consistent Improvement of Atopic ...
ZORYVE demonstrated consistent efficacy in disease clearance and reduction in itch for individuals with atopic dermatitis (AD) regardless of ...
Managed Healthcare Executive17 小时
FDA Accepts sNDA for Foam Psoriasis Drug Zoryve
The FDA has already approved Zoryve cream (0.3% and 0.15%) for plaque psoriasis and atopic dermatitis in adults and children ...